Citius Pharmaceuticals Inc (NASDAQ: CTXR) is -82.31% lower on its value in year-to-date trading and has touched a low of $0.15 and a high of $1.07 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CTXR stock was last observed hovering at around $0.17 in the last trading session, with the day’s loss setting it -0.04%.
Currently trading at $0.13, the stock is -58.62% and -66.16% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 16.05 million and changing -18.96% at the moment leaves the stock -79.08% off its SMA200. CTXR registered -82.58% loss for a year compared to 6-month loss of -79.73%. The firm has a 50-day simple moving average (SMA 50) of $0.395396 and a 200-day simple moving average (SMA200) of $0.637472.
The stock witnessed a -61.33% gain in the last 1 month and extending the period to 3 months gives it a -80.32%, and is -33.10% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 26.90% over the week and 20.42% over the month.
Citius Pharmaceuticals Inc (CTXR) has around 22 employees, a market worth around $20.95M and $0.00M in sales. Distance from 52-week low is -12.49% and -87.50% from its 52-week high. The company has generated returns on investments over the last 12 months (-46.36%).
The EPS is expected to shrink by -4.55% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Citius Pharmaceuticals Inc (CTXR) Top Institutional Holders
66.0 institutions hold shares in Citius Pharmaceuticals Inc (CTXR), with institutional investors hold 13.20% of the company’s shares. The shares outstanding are 193.18M, and float is at 180.01M with Short Float at 6.55%. Institutions hold 12.36% of the Float.
The top institutional shareholder in the company is ARMISTICE CAPITAL, LLC with over 10.16 million shares valued at $5.93 million. The investor’s holdings represent 6.3845% of the CTXR Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 6.33 million shares valued at $3.69 million to account for 3.9776 of the shares outstanding. The other top investors are MILLENNIUM MANAGEMENT LLC which holds 2.05 million shares representing 1.288% and valued at over $1.2 million, while BLACKROCK INC. holds 1.1352 of the shares totaling 1.81 million with a market value of $1.05 million.
Citius Pharmaceuticals Inc (CTXR) Insider Activity
#####
